Author

Ulf Helwig 1

1 Private Praxis,Oldenburg,Germany

A PROSPECTIVE MULTI-CENTER STUDY ON THE PREVALENCE OF FRUCTOSE MALABSORPTION IN PATIENTS WITHCHRONIC INFLAMMATORY BOWEL DISEASE

Ulf Helwig

A prospective multi-center study on the prevalence of fructose malabsorption in patients withchronic inflammatory bowel disease

Ulf Helwig, Anna Katharina Koch, Kliniken Essen-Mitte,Essen,Germany, Christof Reichel, Petra Jessen, Betina Zietz, Jürgen Büning, Stefan Schreiber, Jost Langhorst

BOWEL ULTRASOUND IS USEFUL IN DISEASE MONITORING OF ULCERATIVE COLITIS PATIENTS: FIRST ANALYSIS FROM THE TRUST&UC STUDY IN GERMANY

Christian Maaser, Frauke Petersen, Ulf Helwig, Alexander Rössler, Dorothee Lang, Stefan Rath, Torsten Kucharzik, On behalf of the TRUST&UC study group

EARLY MONITORING OF RESPONSE (MORE) TO GOLIMUMAB THERAPY BASED ON FECAL CALPROTECTIN AND TROUGH SERUM LEVELS IN PATIENTS WITH ULCERATIVE COLITIS: A MULTICENTER PROSPECTIVE OBSERVATIONAL STUDY

Ulf Helwig

Early Monitoring of Response (MORE) to Golimumab Therapy based on Fecal Calprotectin and Trough Serum Levels in Patients with Ulcerative Colitis: A Multicenter Prospective Observational Study

Ulf Helwig, Thomas Krause, Christian Maaser, Jürgen Büning, Attyla Drabik, Margit Blömacher, Niels Teich, Annette Krummenerl, Matthias Schwab, Andreas Sturm, Stefan Schreiber

EXPRESSION OF THE FRUCTOSE TRANSPORTER GLUT5 IN PATIENTS WITH FRUCTOSE MALABSORPTION.

Pia Staubach, Sandra Krüger, Anna Katharina Koch, Jost Langhorst, Christoph Röcken, Ulf Helwig

PERFORMANCE EVALUATION OF DYSBIOSIS STATUS AS A TOOL FOR CLINICAL INVESTIGATION IN PATIENTS WITH FUNCTIONAL GASTROINTESTINAL DISORDERS

Wolfgang Kruis, Torbjørn Lindahl, Elke Christiane Bästlein, Thomas Fiedler, Sven Georgi, Jörg Ringel, Lars Konopka, Michael Mross, Ulf Helwig, Grischa Terheggen, Ewa Ciemniejewska, Christina Casén

REAL-WORLD EFFECTIVENESS OF VEDOLIZUMAB AND ANTI-TUMOUR NECROSIS FACTOR ALPHA TREATMENT OVER 6 MONTHS IN CROHN'S DISEASE PATIENTS: A GERMAN RETROSPECTIVE CHART REVIEW

Ulf Helwig, Michael Mross, Stefan Schubert, Heinz Hartmann, Alina Brandes, Christian Kempf, Jana Knop, Sarah Campbell-Hill, Robert Ehehalt

REAL-WORLD EFFECTIVENESS OF VEDOLIZUMAB AND ANTI-TUMOUR NECROSIS FACTOR ALPHA TREATMENT OVER 6 MONTHS IN CROHN’S DISEASE PATIENTS: A GERMAN RETROSPECTIVE CHART REVIEW

Ulf Helwig

REAL-WORLD EFFECTIVENESS OF VEDOLIZUMAB AND ANTI-TUMOUR NECROSIS FACTOR-ALPHA OVER 6 MONTHS IN ULCERATIVE COLITIS PATIENTS: A GERMAN RETROSPECTIVE CHART REVIEW

Ulf Helwig

Item 1 - 10 / 14
1
2